Mitobridge, Inc. Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Mitobridge, Inc. is a Cambridge, Massachusetts-based biotechnology company focused on identifying and developing small molecule modulators that enhance mitochondrial function. The company aims to leverage advances in mitochondrial biology to address diseases by pharmacologically influencing mitochondrial pathways, with potential applications in metabolic and musculoskeletal disorders, including conditions with a genetic component. Its drug discovery platform seeks compounds that improve mitochondrial performance or correct dysfunction, pursuing candidates that could treat diseases affecting both rare and more widespread patient populations. Mitobridge serves researchers and pharmaceutical partners seeking novel mitochondrial-targeted therapies, pursuing collaborations to advance these candidates. It has an experienced management and scientific team and was founded by leaders in mitochondrial biology and metabolism. A notable recent development is a collaboration with Astellas Pharma established in 2021.